Techstars AI Health Baltimore
HealthTech & MedTech · Run by Techstars · Baltimore, MD
Every field is checked against a primary source where we can. How we verify.
The facts
All fields verified Aug 26, 2026- Terms model
- Equity for cashInvests cash in your company and takes equity (an ownership stake) in return.
- Investment
- $220,000
- Equity taken
- 5% common stock via $20,000 convertible equity agreement, plus $200,000 uncapped MFN post-money SAFE (standard Techstars terms)
- Program length
- 13 weeks
- Format
- In person
- Location
- Baltimore, MD
- Cohorts per year
- 1
- Cohort size
- Not published
- Stage focus
- early-stage AI health
- Sub-vertical
- AI in healthcare
- Demographic focus
- Not published
- Backers
- Johns Hopkins, CareFirst BlueCross BlueShield, MedStar Health, University of Maryland Baltimore, University of Maryland Medical System
- Notable alumni
- Not published
Terms notes: Techstars invests $220,000 per company (standard Techstars terms: typically $20k + $200k uncapped SAFE for a combined equity position; exact % not stated on fetched program page, so null - see techstars.com/newsroom/investment-terms). Anchor partners: Johns Hopkins, CareFirst BCBS, MedStar Health, University of Maryland Baltimore, UMMS. Positioned as Techstars' flagship healthcare accelerator. DEADLINE/STATUS NOTE: 2026 final application deadline was June 10, 2026 (now passed); program runs Sept 8 - Dec 3, 2026. Next application window expected spring 2027, so next_deadline null as of July 21, 2026.
Get HealthTech & MedTech deadline alerts
One digest a week. Deadline alerts only for verticals you pick. Unsubscribe anytime.
Terms in plain English
Techstars invests $220,000 per company on its standard terms: $20,000 through a convertible equity agreement for 5% of the company in common stock, plus a $200,000 uncapped post-money SAFE with a most favored nation clause that converts at a future priced equity round of at least $1 million. There is no fee to join the program. The accelerator runs in person in Baltimore for about 13 weeks, with anchor partners including Johns Hopkins, CareFirst BlueCross BlueShield, MedStar Health, University of Maryland Baltimore, and the University of Maryland Medical System.
Who this is actually for
Early-stage founders building AI-driven healthcare products who want structured access to major Baltimore health systems and payers. You need to be able to work in person in Baltimore for the roughly 13-week program, which runs September through early December.
Techstars AI Health Baltimore application deadlines
Frequently asked questions
- When is the next Techstars AI Health Baltimore application deadline?
- The next confirmed application window for Techstars AI Health Baltimore closes Nov 18, 2026.
- How much does Techstars AI Health Baltimore invest?
- Techstars AI Health Baltimore lists an investment of $220,000.
- How much equity does Techstars AI Health Baltimore take?
- Techstars AI Health Baltimore lists equity of 5% common stock via $20,000 convertible equity agreement, plus $200,000 uncapped MFN post-money SAFE (standard Techstars terms).
- Where is Techstars AI Health Baltimore located and is it in person?
- Techstars AI Health Baltimore is based in Baltimore, MD and runs an in person program.
- Is Techstars AI Health Baltimore still active?
- As of our last check on Aug 26, 2026, Techstars AI Health Baltimore is active.
Compare this program
Put Techstars AI Health Baltimore side by side with up to two others to weigh cash, equity, and timing.
Compare Techstars AI Health BaltimoreGuides that explain these terms
Plain-English mechanics, with worked hypothetical numbers.
- How much equity do accelerators take?Why there is no single equity number for accelerators, and how the stake depends on the funding model a program uses.
- Techstars terms explainedA plain-English breakdown of Techstars' published standard investment terms, piece by piece, with worked dilution math at three hypothetical valuations.
- How to choose a healthtech acceleratorA decision guide for health and medtech founders weighing clinical validation, regulatory support, and payer access against equity.
- What 5 percent common stock actually costsTranslating a small-sounding equity number into real dollars across a range of exit outcomes.
More like Techstars AI Health Baltimore
Sources
Everything above was checked against these, verified Aug 26, 2026.